Introduction
Digestion is a complex process that is essential for health wherein ingested food is broken down into nutrients that can be used by the human body for growth, maintenance, and energy. During human digestion, the 2 main processes that occur simultaneously are mechanical transformations that reduce the size of food components and enzymatic transformations where macromolecules are hydrolyzed into smaller elements that are absorbed into the bloodstream (1) . Food disintegration commonly occurs in the mouth and stomach, whereas enzymatic digestion and absorption of nutrients takes place in the small intestine. Non-absorbed materials travel to the large intestine for absorption of water and electrolytes, reabsorption of bile salts, formation, storage, and elimination of feces, and fermentation of polysaccharides and phytochemicals by gut microbiota (2) .
Gut microbiota are improtant for human health primarily in absorption of nutrients and energy, and other roles (3) . In particular, microbial infections and imbalances of gut microbiota are related to inflammatory bowel diseases, and to other immune related disorders (4, 5) . Although genetic and environmental factors influence the balance of gut microbiota, diet also affects microbial fermentation and the microbial compositional balance in the human intestine (6) . In vivo testing involving use of humans and animals would be the best models for investigation of diet effects on intestinal microbiota. However, such testing is often expensive and time consuming, usually with limited study numbers. Animal testing is also becoming unpopular for ethical reasons. Furthermore, many of these types of investigations suffer from low compliance and high drop-out rates (7) . These problems can be solved using in vitro methods. In vitro fermentation gut models involve use of pure cultures, mixed cultures, and human feces, and can range from simple batch style fermentations performed in serum bottles to sophisticated pHcontrolled multistage continuous culture systems (7) . Therefore, the aim of this review is to introduce potential and perspective advances based on in vitro gut fermentation models for development of novel functional food components.
Human large intestine The human large intestine contains 10 colon, and 10 12 cells/g in the distal colon (Fig. 1 ). Using microflora, the colon is capable of complex hydrolytic digestive functions involving breakdown of dietary complex carbohydrates and some proteins that are not hydrolyzed or absorbed in the upper digestive tract. The level of carbohydrate consumption is subsequently lowered in the transverse and descending portions of the colon (8) .
The large intestine is the area most populated with microflora due to favorable conditions, including slow gut transit times, nutrient availability, and a favorable pH (8) . Up to 10 12 microbes per g inhabit the colon, accounting for a total of 1-2 kg of human body weight. Over 50 bacterial phyla have been identified, but human-associated microbiota are dominated by only the 4 main phyla of Firmicutes, Bacteroidetes, Actinobacteria, and Proteobacteria (9, 10) . Inclusion of Clostridia within Firmicutes makes it the phylum containing the most members represented in the microbiota, constituting 46-58% of total gut bacteria (11, 12) . Intestinal metabolism involves a variety of enzymes and biochemical pathways provided by specialized members of the microbial community that are distinct from host supplied resources. This metabolic capacity is estimated to be encoded in a total of 2-4 million microbial genes, which is 70-140x greater than the number of genes in the human genome (13, 14) . Initial digestion processes in the human intestine require specific microbial glycosidases encoded in the DNA of hydrolytic gut microbiota. These microbes hydrolyze otherwise indigestible polysaccharides, such as resistant starch, both soluble and insoluble dietary fiber, proteins or host-innate mucins, such as glycosylated high Mw proteins, and phytochemicals reaching the large intestine. Subsequent microbial fermentation of hydrolyzed non-absorbed material in the large intestine results in production of short chain fatty acids (SCFAs), such as acetate, propionate, and butyrate, branched chain fatty acids, as well as lactate, formate, ethanol, and mixed gases, such as CH 4 , CO 2, and H 2 (15) . Dissimilatory metabolic processing of proteinaceous material produces ammonia, amines, mercaptans, and H 2 S, as well as some toxic indolic and phenolic compounds (16) . SCFA production resulting from microbial fermentation of hydrolyzed dietary fibers, and sugars provides an estimated 10% of daily dietary energy resources to the host (17) (18) (19) .
In vitro fermentation models Design of in vitro fermentation systems includes simple batch cultures and single-stage or multistage continuous flow models that use different fecal inoculation (7, (20) (21) (22) . In vitro gut fermentation models allow stable cultivation of gut microbiota for a known period of time. Selection of a proper model requires cautious evaluation for research purposes considering both the advantages and limitations of different systems (Table 1) . Each system type uses a different medium for microbial cell growth (Table  2 ).
In vitro gut models for digestion and/or fermentation Batch fermentation models are closed systems in which microorganisms grow in a fermenter after cell inoculation ( Fig. 2A) . Batch cultures are inexpensive and easy to set up and are especially useful for determining metabolite profiles produced by fecal microflora that consume diet components (23) and are, therefore, used for fast testing of different substrates or fecal samples (7). However, substrate depletion and pH change during batch fermentations can result in distorted fermentation profiles based on a lack of steady state conditions and, thus, these methods are used for limited purposes of short-term testing (23) . Uninterrupted medium flow through continuous culture fermentation models is regarded as a better system for mimicking in vivo contitions (7, 23) . Continuous fermentation chemostat models in which fresh medium is added and spent medium is removed allows long-term testing with high cell density cultures (7). Single-stage models consist of a single fermenter jar corresponding to a part of the gastrointestinal (GI) tract, whereas multi-stage models consist of several jars corresponding to multiple parts of the GI tract, such as the ascending, transverse, and descending colons (Fig. 2B) . Operation of most in vitro systems requires a liquid fecal suspension as an inoculum, resulting in several limitations due to the free-cell state of bacterial populations (21) . Systems with liquid fecal inocula generally experience a rapid washout of less competitive bacteria and are, consequently, limited in operational time to less than 4 weeks (24) (25) (26) . These systems also fail to reproduce both the planktonic free-cell and sessile biofilm-associated states of bacterial populations in the colon (7, (27) (28) (29) . To address problems associated with inoculum washout, a process for immobilization of fecal microbiota has been developed (21,28) wherein fecal microbiota are suspended within a porous polysaccharide matrix resulting in formation of fecal beads. The beads are transferred to the first part of a multistage continuous fermentation model (Fig. 2C) . Limitations of substrate and toxic product diffusion within beads result in formation of a high-cell density peripheral layer in which cell release occurs spontaneously as a result of active cell growth (21, (30) (31) (32) . The operational system time for studies using immobilized cells varies and has been functionally demonstrated for time frames of 29, 54, and up to 71 days (21, 33, 34) .
Digestion and fermentation systems include simulation of the human intestinal microbial ecosystem (SHIME), as a multi-stage sequential batch model of semi-continuous culture (Fig. 2D) . The system has 5 fermenter jars connected in series corresponding to the stomach and the small intestine, and the ascending, transverse, and descending portions of the colon. Working volumes in these vessels are 300 mL for the stomach and small intestine, 1,000 mL for the ceacum and ascending colon, 1,600 mL for the transverse colon, and 1,200 mL for the desending colon. The system is inoculated using daily introduction of a 10 mL supernatant of a human diet suspension into the first vessels for 8 successive days. The remaining 3 vessels representing the 3 different compartments of the colon are inoculated with a 50 mL of a fecal suspension for 10 successive days. Contents of these vessels are pumped continuously from vessel to vessel and finally to a discard bottle. The transit time of the system is 84 h (35).
In vitro gut models for digestion-fermentation-absorption Artificial digestion-fermentation-absorption systems have been developed based on modification of multi-stage gut fermentation models to mimic human physiological functions (23) . In vitro gut models for digestion-fermentation-absorption differ from in vitro models for digestion and/or fermentation in that, during fluid transportation, water is absorbed apart from fermentation products using dialysis membranes.
There are 2 TNO (Dutch Organization for Applied Scientific Research) Intestinal Models (TIMs) known as the TIM-1 small intestine model, which is equipped for functions of the upper intestine, such as bile secretion, motility, pH control, and absorption (Fig. 3A) (36,37) , and the TIM-2 proximal colon model, which is equipped for functions of the proximal colon like peristaltic mixing and metabolite absorption (Fig. 3B) (38) . The TIM-1 and TIM-2 models have also been combined for investigation of the nutritional effects of novel food compounds, and for pharmaceutical studies (36,39-41). For TIM-1, a homogenized human meal is introduced into the gastric compartment at pre-set times and the homogenate is pumped through the system. During 
Multistage continuous the operational period, secretion of enzymes, bile, and pancreatic juice and pH-control of the stomach in a gradient from 5.0 to 1.8 for 80 min from the beginning while maintaining the duodenum at a constant pH of 6.5, are regulated using a computer. For TIM-2, 200 mL of a fecal inoculum is first introduced and fecal microbiota are allowed to adapt to conditions for 16 h, after which the actual simulation is started based on addition of an ileal environment medium semi-continuously with or without the tested substate. The pH value is constantly maintained at 5.8 for representation of the pH level in the proximal colon.
Monitoring of the gut microbiotal composition Culture-based techniques used for bacterial identification are laborious and timeconsuming, and provide a limited view of the diversity and dynamics of the GI microbiota with less than 30% of gut microbiota taxa having been cultured to date (9) . Since the 1990s, introduction of novel molecular biological procedures has made it possible to overcome some of these limitations based on culture-independent methods (10) based on sequence divergence, including techniques such as denaturing gradient gel electrophoresis (DGGE) (42), terminal restriction fragment length polymorphism (TRFLP) (43) , fluorescence in situ hybridization (FISH) (4), quantitative polymerase chain reaction (qPCR) (44) , DNA microarray analysis (5), and next-generation sequencing (NGS) (43) . FISH has been used for quantification of 
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Fermentation conditions for type of study, food components, duration, and dosage, and microbial techniques used, and main effects on bacteria groups, such as population increase and decrease, are included.
bacterial cells with 16S rRNA-targeted oligonucleotide probes combined with fluorescent light microscopy, confocal laser microscopy, or flow cytometry (11) . FISH-based bacterial enumeration is based on cell counts and, consequently, provides accurate quantification. Recently, a qPCR method has been used for quantification of different microfloral taxa within a large population. The main benefit of this technique is speed and the possibility for detection of minor populations of bacteria within microbial communities (12) . For detection of a genus, a species, or a strain of microorganism, a primer set is designed to be genus, species, or strain-specific and PCR amplification with primers can be conducted. Comparison of cycles to threshold (Ct) values for each species in unknown cultures with reference cultures gives the cell number of the strain in the unknown mixed culture, determined based on colony forming units on agar plates (45) .
Food studies using in vitro gut fermentation models Different modulation studies of gut microbiota using different food components with in vitro gut fermentation models are shown in Table 3 . Details of fermentation conditions, including type of study, food components, duration, and dosage, microbial techniques used, and main effects on bacteria groups, such as population increase and decrease, have been included. Prebiotic effects of fructo-, galacto-, xylo-, isomalto-, and arabino-oligosaccharides and inulin, dextran, and arabinan polysaccharides have been examined using both batch and continuous models. Phytochemicals and polyphenolic compounds have been used for testing of prebiotic and microbiota modulatory effects in the large intestine. Among phytochemicals, gallic acid and derivatives showed potential prebiotic effects. Moreover, complex food substances, including soy germ powder, black tea extracts, red wine, and grape juice, have been used for investigation of effects on microbiota in the large intestine.
Prebiotic effects of arabino-oligosaccharides were investigated in our previous study using an in vitro batch fermenter and they were slowly degraded compared with fructo-oligosaccharides, possibly permitting SCFA production in the distal colon. This result demonstrated that arabino-oligosaccharides are promising dietary substrates for human health (44) . Using the SHIME model, De Boever et al. (46) found that addition of soy germ powder during a 2 week treatment period resulted in a significant increase of 2 log10 units in the Lactobacillus spp. population. More recently, Kemperman et al. (47) , using the twin-SHIME model, studied the influence of complex dietary polyphenols from black tea and red wine grape extracts on colonic microbiota, showing that these complex polyphenols, in the context of a model system, can modulate select members of the human gut microbiota.
In conclusion, in vitro fermentation models provide innovative technological platforms with a virtually limitless experimental capacity and no restrictions based on ethical concerns. To mimic the human GI tract, further improvement of in vitro fermentation models is needed. Use of a combined model system comprising in vitro gut compartments coated with the human intestinal cell lines Caco-2 and HT-29 may provide useful information on host responses to colonal fermentation, including competitive colonization and adhesion between beneficial and harmful or pathogenic bacteria, inhibitory activity of prebiotics on attachment of harmful bacteria, and immune modulatory activity of prebiotics and probiotics. Standardization of medium compositions used in an in vitro gut fermenation model is also necessary for different ethnic groups that follow dietary restrictions.
